Meyer O - Search Results

1

Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients.

Koster A, Huebler S, Potapov E, Meyer O, Jurmann M, Weng Y, Pasic M, Drews T, Kuppe H, Loebe M, Hetzer R. Koster A, et al. Among authors: meyer o. Ann Thorac Surg. 2007 Jan;83(1):72-6. doi: 10.1016/j.athoracsur.2006.05.077. Ann Thorac Surg. 2007. PMID: 17184633

2

In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.

Koster A, Meyer O, Hausmann H, Kuppe H, Hetzer R, Mertzlufft F. Koster A, et al. Among authors: meyer o. J Clin Anesth. 2000 Jun;12(4):324-7. doi: 10.1016/s0952-8180(00)00165-3. J Clin Anesth. 2000. PMID: 10960207 Clinical Trial.

3

Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.

Koster A, Kukucka M, Bach F, Meyer O, Fischer T, Mertzlufft F, Loebe M, Hetzer R, Kuppe H. Koster A, et al. Among authors: meyer o. Anesthesiology. 2001 Feb;94(2):245-51. doi: 10.1097/00000542-200102000-00013. Anesthesiology. 2001. PMID: 11176088

4

Some new perspectives in heparin-induced thrombocytopenia type II.

Koster A, Meyer O, Hetzer R, Kuppe H. Koster A, et al. Among authors: meyer o. J Extra Corpor Technol. 2001 Sep;33(3):193-6. J Extra Corpor Technol. 2001. PMID: 11680734 Review.

5

One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.

Koster A, Meyer O, Fischer T, Kukucka M, Krabatsch T, Bauer M, Kuppe H, Hetzer R. Koster A, et al. Among authors: meyer o. J Thorac Cardiovasc Surg. 2001 Dec;122(6):1254-5. doi: 10.1067/mtc.2001.118271. J Thorac Cardiovasc Surg. 2001. PMID: 11726910 Free article. No abstract available.

6

Amlodipine-induced immune thrombocytopenia.

Garbe E, Meyer O, Andersohn F, Aslan T, Kiesewetter H, Salama A. Garbe E, et al. Among authors: meyer o. Vox Sang. 2004 Jan;86(1):75-6. doi: 10.1111/j.0042-9007.2004.00376.x. Vox Sang. 2004. PMID: 14984564

7

[Heparin-induced type II thrombocytopenia in intensive care].

Koster A, Meyer O, Kukucka M, Mertzlufft F, Kuppe H. Koster A, et al. Among authors: meyer o. Wien Klin Wochenschr. 2001;113 Suppl 1:14-8. Wien Klin Wochenschr. 2001. PMID: 15503587 German. No abstract available.

8

Report of a patient with heparin-induced thrombocytopenia type II associated with IgA antibodies only.

Meyer O, Aslan T, Koster A, Kiesewetter H, Salama A. Meyer O, et al. Clin Appl Thromb Hemost. 2006 Jul;12(3):373-5. doi: 10.1177/1076029606291400. Clin Appl Thromb Hemost. 2006. PMID: 16959694 Free article.

9

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R. Bolbrinker J, et al. Among authors: meyer o. Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24. Pharmacoepidemiol Drug Saf. 2017. PMID: 28544026

10

The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays.

Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A. Eichler P, et al. Among authors: meyer o. Br J Haematol. 2002 Mar;116(4):887-91. doi: 10.1046/j.0007-1048.2002.03363.x. Br J Haematol. 2002. PMID: 11886396 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

867 results

Search Page

Filters